Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study

dc.contributor.authorCárdenas, Andrés
dc.contributor.authorSolà, Elsa
dc.contributor.authorRodríguez Gullello, Ezequiel Alejandro
dc.contributor.authorBarreto, Rogelio
dc.contributor.authorGraupera, Isabel
dc.contributor.authorPavesi, Marco
dc.contributor.authorSaliba, Faouzi
dc.contributor.authorWelzel, Tania Mara
dc.contributor.authorMartínez González, Javier
dc.contributor.authorGustot, Thierry
dc.contributor.authorBernardi, Mauro
dc.contributor.authorArroyo, Vicente
dc.contributor.authorGinès i Gibert, Pere
dc.date.accessioned2018-03-13T17:34:21Z
dc.date.available2018-03-13T17:34:21Z
dc.date.issued2014-12-13
dc.date.updated2018-03-13T17:34:21Z
dc.description.abstractINTRODUCTION: Hyponatremia is a marker of poor prognosis in patients with cirrhosis. This analysis aimed to assess if hyponatremia also has prognostic value in patients with acute-on-chronic liver failure (ACLF), a syndrome characterized by acute decompensation of cirrhosis, organ failure(s) and high short-term mortality. METHODS: We performed an analysis of the Chronic Liver Failure Consortium CANONIC database in 1,341 consecutive patients admitted to 29 European centers with acute decompensation of cirrhosis (including ascites, gastrointestinal bleeding, hepatic encephalopathy, or bacterial infections, or any combination of these), both with and without associated ACLF (301 and 1,040 respectively). RESULTS: Of the 301 patients with ACLF, 24.3% had hyponatremia at inclusion compared to 12.3% of 1,040 patients without ACLF (P <0.001). Model for end-stage liver disease, Child-Pugh and chronic liver failure-SOFA scores were significantly higher in patients with ACLF and hyponatremia compared to those without hyponatremia. The presence of hyponatremia (at inclusion or during hospitalization) was a predictive factor of survival both in patients with and without ACLF. The presence of hyponatremia and ACLF was found to have an independent effect on 90-day survival after adjusting for the potential confounders. Hyponatremia in non-ACLF patients nearly doubled the risk (hazard ratio (HR) 1.81 (1.33 to 2.47)) of dying at 90 days. However, when considering patients with both factors (ACLF and hyponatremia) the relative risk of dying at 90 days was significantly higher (HR 6.85 (3.85 to 12.19) than for patients without both factors. Patients with hyponatremia and ACLF had a three-month transplant-free survival of only 35.8% compared to 58.7% in those with ACLF without hyponatremia (P <0.001). CONCLUSIONS: The presence of hyponatremia is an independent predictive factor of survival in patients with ACLF. In cirrhosis, outcome of patients with ACLF is dependent on its association with hyponatremia.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec649508
dc.identifier.issn1364-8535
dc.identifier.pmid25643318
dc.identifier.urihttps://hdl.handle.net/2445/120686
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s13054-014-0700-0
dc.relation.ispartofCritical Care, 2014, vol. 18, num. 6, p. 700
dc.relation.urihttps://doi.org/10.1186/s13054-014-0700-0
dc.rightscc-by (c) Cárdenas, Andrés et al., 2014
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationMalalties del fetge
dc.subject.classificationInsuficiència hepàtica
dc.subject.classificationMedicina interna
dc.subject.otherLiver diseases
dc.subject.otherLiver failure
dc.subject.otherInternal medicine
dc.titleHyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
649508.pdf
Mida:
307.78 KB
Format:
Adobe Portable Document Format